Abstract. Skeletal muscle atrophy is a debilitating condition associated with a variety of pathological conditions (e.g. diabetes mellitus, cancer, chronic obstructive pulmonary disease, and chronic heart failure), physiological consequence of aging (sarcopenia), and disuse (e.g. casting-immobilization, microgravity, or tendon injury), subsequently leading to a decrease in mobility and reduced quality of life (1). Muscle atrophy is characterized by a decrease of protein content leading to a reduction in cross-sectional area (CSA) of muscle fibers and impairment of muscle force generation and fatigue resistance (2, 3). Skeletal muscle mass is determined by the balance of protein synthesis and protein breakdown. However, previous compelling evidence has indicated that disuse muscle atrophy is primarily caused by the increase in the rate of protein degradation rather than a decrease in the rate of protein synthesis (4). Although several proteolytic systems are involved in protein turnover in skeletal muscle, recent studies suggested that the ubiquitin-proteasome system (UPS) represents the major intracellular proteolysis machinery responsible for the degradation of major contractile proteins, and contributes significantly to muscle atrophy in both animal and human models (1, 5).To date, in spite of many attempts, there is no single effective method to completely cure muscle atrophy. Although several pharmacological agents such as β2-adrenergic agonist or proteasome inhibitors have been prescribed to combat muscle atrophy (5), these drugs do not come without side-effects. Therefore, a search for a nonpharmacological therapeutic strategy should be considered as an alternative approach to tackle these clinical problems. There is evidence that ecdysteroids, insect hormones, have an anabolic effect on skeletal muscle (6) with no side-effects in mammals, including humans (7).Ecdysteroids act as molting hormones in insects and also play a defensive role against insect herbivory in plants (8).There are a large number of structurally related ecdysteriods in plants (phytoecdysteriods). Of these, 20-hydroxyecdysone (20E) is the most commonly found and extensively studied. This compound is present at high concentration in the bark of blackberry tree (Vitex glabrata). 20E has low toxicity in mammals: the lethal dose 50 (LD 50 ) is 6.4 g/kg in mice for intraperitoneal injection and more than 9 g/kg when given orally (9). The pharmacokinetics of 20E depend on the mode of administration, for example, the half-time of elimination of this substance in lambs when administered via oral, intravenous, and intramuscular routes were 0.2, 0.4, and 2 h, respectively (10). It has been reported that the half-life of